company tower banner
Wacker Chemie AG Company Logo

Products

Wacker Chemie AG

11 Products found on Wacker Chemie AG in Formulation & Processing Aids

With SDS
With TDS
SILFAR® 100 banner
Wacker Chemie AG company logo
SILFAR® 100
  • Chemical Name:Polydimethylsiloxane
  • CAS Number:9006-65-9
  • Functions:Defoamer
  • Labeling Claims:Animal Products-free, BSE-free, TSE-free
  • Certifications & Compliance:United States Pharmacopeia (USP), Regulation (EU) No. 10/2011 (PIM), FDA 21 CFR 176.200, Coalition of Northeastern Governors (CONEG), Regulation (EU) No. 1169/2011, FDA 21 CFR 175.105, FDA 21 CFR 177.1200, Regulation (EU) No. 2019/1021, Directive 2011/65/EC amended through EU/2015/863 (RoHS), BfR 36/2 Recommendation , Directive 2000/53/EC, GB 9685-2016, Waste Electrical & Electronic Equipment Directive (WEEE), FDA 21 CFR 178.3120, EC No. 1935/2004, BfR 14 Recommendation, BfR 15 Recommendation, BfR Recommendation, FDA 21 CFR 175.300, FDA 21 CFR 177.2260, EU Packaging Directive (94/62/EC), Swiss Ordinance (SR 817.023.21), FDA 21 CFR 177.1210, National Formulary (NF), BfR 36 Recommendation, GB 4806.1-2016, FDA 21 CFR 176.210, Regulation (EC) No. 1005/2009, European Pharmacopeia (Ph. Eur.), cGMP, ISO 9001, FDA 21 CFR 177.2800, ISO 14001, BSE & TSE, FDA 21 CFR 176.180, Consumer Product Safety Improvement Act (CPSIA), FDA 21 CFR 176.170
  • Synonyms:Dimethicone
SILFAR® 100 is a polydimethylsiloxane derived from the hydrolysis and polycondensation of dichlorodimethylsilane and chlorotrimethylsilane. Its degree of polymerization (n) is adjusted to achieve a mean kinematic viscosity of 100 mm²/s at 25°C. This product finds primary application in the pharmaceutical sector, particularly as a fundamental raw material in pharmaceutical formulations.
HDK® N20 P Pharma banner
Wacker Chemie AG company logo
HDK® N20 P Pharma
  • Functions:Glidant, Flow Promoter
  • Chemical Name:Pyrogenic Silica
  • Labeling Claims:Animal Products-free, TSE-free, BSE-free, GMO-free, Non-GMO
  • Certifications & Compliance:Directive 2011/65/EC amended through EU/2015/863 (RoHS), Consumer Product Safety Improvement Act (CPSIA), Directive 2003/15/EC, FDA 21 CFR 178.3120, FDA 21 CFR 178.3570, EC No.1907/2006, FDA 21 CFR 175.350, FDA 21 CFR 175.105, BSE & TSE, Coalition of Northeastern Governors (CONEG), BfR 52 Recommendation , Directive 2010/75/EU, ISO 9001, European Pharmacopeia (Ph. Eur.), Directive 2001/83/EC, EC No. 1935/2004, FDA 21 CFR 182.90, National Formulary (NF), FDA 21 CFR 176.200, United States Pharmacopeia (USP), GB 9685-2016, FDA 21 CFR 177.2420, FDA 21 CFR 176.210, ISO 14001, Regulation (EU) No. 10/2011 (PIM), Hazard Analysis Critical Control Point (HACCP), FDA 21 CFR 176.170, BfR Recommendation, Directive 2000/53/EC, FDA 21 CFR 177.2600, FDA 21 CFR 176.180, Regulation (EU) No. 1169/2011, FDA 21 CFR 178.3297, FDA 21 CFR 177.1400, USP Class IV, FDA 21 CFR 177.1200, FDA 21 CFR 175.300, Generally Recognized As Safe (GRAS), FDA 21 CFR 175.390, Swiss Ordinance (SR 817.023.21), EU Packaging Directive (94/62/EC)
  • Dosage Form:Tablets, Powder & Powder Blends
  • Synonyms:Fumed Silica, Silica, Silicon Dioxide
HDK® N20 P Pharma is a synthetic, hydrophilic, amorphous silica powder produced via flame hydrolysis. It is a white, high-purity colloidal powder. This product serves as a glidant for tableting, effectively improving the flow of powders. Furthermore, HDK® N20 P Pharma undergoes testing according to the EP and USP/NF standards.